Prevalenza nel mondo reale e conseguenze delle potenziali interazioni farmaco-farmaco nei trattamenti COVID-19 di prima ondata

Real‐world prevalence and consequences of potential drug‐drug interactions in the first‐wave COVID‐19 treatments Noemí Martínez‐López‐de‐Castro PharmD, PhD ; Marisol Samartín‐Ucha PharmD, PhD ; Adolfo Paradela‐Carreiro PharmD, PhD ; Antonio Pérez‐Landeiro PharmD ; María Teresa Inaraja‐Bobo PharmD, PhD ; Miriam Álvarez‐Payero PharmD ; Inés Castro‐Núñez PharmD ; Nerea García‐Beloso PharmD ; David Robles‐Torres PharmD ; Aida López‐López PharmD ; Sonia González‐Costas PharmD ; Belén Leboreiro‐Enríquez PharmD ; Luis…